PEN

$0.00

(

+0.00%

)
Quote details

stock

Penumbra Inc

NYSE | PEN

255.91

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$10.16B

Market Cap

68.91

P/E Ratio

3.78

EPS

$310.00

52 Week High

$198.68

52 Week Low

HEALTHCARE

Sector

PEN Chart

Recent Chart
Price Action

PEN Technicals

Tags:

PEN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $755M
Total Revenue $1.2B
Cost Of Revenue $440M
Costof Goods And Services Sold $440M
Operating Income $9.3M
Selling General And Administrative $574M
Research And Development $95M
Operating Expenses $746M
Investment Income Net -
Net Interest Income $12M
Interest Income $14M
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax $21M
Income Tax Expense $6.9M
Interest And Debt Expense -
Net Income From Continuing Operations $14M
Comprehensive Income Net Of Tax -
Ebit $22M
Ebitda $46M
Net Income $14M

Revenue & Profitability

Earnings Performance

PEN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.5B
Total Current Assets $951M
Cash And Cash Equivalents At Carrying Value $324M
Cash And Short Term Investments $324M
Inventory $407M
Current Net Receivables $168M
Total Non Current Assets $582M
Property Plant Equipment $268M
Accumulated Depreciation Amortization Ppe -
Intangible Assets $6.5M
Intangible Assets Excluding Goodwill $6.5M
Goodwill $166M
Investments -
Long Term Investments -
Short Term Investments $16M
Other Current Assets $37M
Other Non Current Assets -
Total Liabilities $382M
Total Current Liabilities $158M
Current Accounts Payable $31M
Deferred Revenue -
Current Debt -
Short Term Debt $15M
Total Non Current Liabilities $224M
Capital Lease Obligations $223M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $223M
Other Current Liabilities $112M
Other Non Current Liabilities $15M
Total Shareholder Equity $1.2B
Treasury Stock -
Retained Earnings $60M
Common Stock $38K
Common Stock Shares Outstanding $39M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $168M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $24M
Capital Expenditures $21M
Change In Receivables -
Change In Inventory -$66M
Profit Loss -
Cashflow From Investment $78M
Cashflow From Financing -$87M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$100M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $14M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $755M
Total Revenue $1.2B
Cost Of Revenue $440M
Costof Goods And Services Sold $440M
Operating Income $9.3M
Selling General And Administrative $574M
Research And Development $95M
Operating Expenses $746M
Investment Income Net -
Net Interest Income $12M
Interest Income $14M
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $24M
Income Before Tax $21M
Income Tax Expense $6.9M
Interest And Debt Expense -
Net Income From Continuing Operations $14M
Comprehensive Income Net Of Tax -
Ebit $22M
Ebitda $46M
Net Income $14M

PEN News

PEN Profile

Penumbra Inc Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Penumbra, Inc. is a leading medical device company that specializes in designing, developing, and manufacturing innovative products aimed at treating neurological and vascular conditions. Headquartered in Alameda, California, the company operates globally, with a presence in key markets such as the United States, Europe, Canada, and Australia. Penumbra's commitment to advancing healthcare through cutting-edge technology positions it as a critical player in the medical device industry, focusing on enhancing patient outcomes and clinician experience.

VHAI
+66.66%
$0.00
UGRO
+58.53%
$0.58
YYAI
-9.70%
$0.15
BURU
-18.90%
$0.41
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
BITF
+11.87%
$6.03
NVDA
-3.57%
$181.59
NVTS
+28.93%
$12.85
TMQ
+47.54%
$9.67
PLUG
-0.25%
$3.89
CAN
+17.43%
$1.78
DNN
+5.19%
$3.24
RGTI
+1.74%
$55.87
BYND
-22.11%
$0.80
LAES
+19.88%
$7.34
ITP
+24.30%
$0.32
EDHL
+95.69%
$0.97
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
F
+1.81%
$11.75
CRML
+28.39%
$29.88
RXRX
+2.35%
$5.66
MNTS
+24.47%
$1.78
IONZ
+6.91%
$2.45
JOBY
+8.19%
$18.14
DVLT
+14.70%
$1.95
NAK
+2.81%
$2.73
DFLI
+44.03%
$1.57
ACHR
+2.46%
$13.08
GPUS
-6.62%
$0.40
AMD
+3.30%
$223.58
TSLA
-0.54%
$433.54
WULF
+12.21%
$15.71
ETHD
+5.41%
$3.51
TLRY
-2.96%
$1.63
MARA
+11.24%
$22.51
MP
+21.34%
$95.06
ERIC
+19.76%
$9.78
QBTS
+7.17%
$43.53
SOUN
+9.19%
$20.90
NUAI
+28.95%
$3.03
UUUU
+11.50%
$26.50
BTBT
+7.50%
$4.30
RR
+0.79%
$6.50
UAMY
+36.85%
$16.71
AAL
+3.79%
$12.18
KDLY
-1.56%
$0.85
RIG
-2.34%
$3.12
BBD
+2.34%
$3.16
CLF
+2.20%
$14.13
SOFI
+3.38%
$28.05
NOK
-1.31%
$5.25
JDZG
+44.14%
$2.71
CIFR
+3.93%
$21.14
AREC
+30.92%
$6.51
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AMZN
+1.71%
$220.07
ADAP
-10.05%
$0.16
CLSK
+11.02%
$22.25
IREN
+9.35%
$70.14
APLD
+4.26%
$35.70
USAR
+2.43%
$39.62
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
BTG
+1.22%
$5.37
NIO
-3.06%
$6.95
WWR
+21.67%
$3.11
ABAT
+18.65%
$10.94
QUBT
+3.86%
$22.29
QS
-1.38%
$16.75
ASST
-5.09%
$1.02
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RF
+2.42%
$25.15
BMNR
-4.52%
$54.28
ONDS
-3.93%
$10.38
WLGS
-5.57%
$0.04
SNAP
-0.64%
$7.99
ETWO
0.00%
$3.30
JBLU
+9.45%
$4.98
GWH
-19.99%
$7.24
AMC
-2.71%
$2.87
RGTZ
-3.00%
$9.02
EOSE
+2.55%
$17.48
PFE
-0.14%
$24.69
WFC
+8.33%
$85.49
NB
+6.80%
$12.09
BCRX
-11.29%
$6.24
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
HPE
+1.73%
$25.23
BAC
+3.18%
$50.41
ABEV
+1.40%
$2.17
AQMS
+140.56%
$23.84
GWAV
+88.96%
$16.08
GDXD
+0.44%
$0.73
GRAB
+0.59%
$5.96
VHAI
+66.66%
$0.00
UGRO
+58.53%
$0.58
YYAI
-9.70%
$0.15
BURU
-18.90%
$0.41
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
BITF
+11.87%
$6.03
NVDA
-3.57%
$181.59
NVTS
+28.93%
$12.85
TMQ
+47.54%
$9.67
PLUG
-0.25%
$3.89
CAN
+17.43%
$1.78
DNN
+5.19%
$3.24
RGTI
+1.74%
$55.87
BYND
-22.11%
$0.80
LAES
+19.88%
$7.34
ITP
+24.30%
$0.32
EDHL
+95.69%
$0.97
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
F
+1.81%
$11.75
CRML
+28.39%
$29.88
RXRX
+2.35%
$5.66
MNTS
+24.47%
$1.78
IONZ
+6.91%
$2.45
JOBY
+8.19%
$18.14
DVLT
+14.70%
$1.95
NAK
+2.81%
$2.73
DFLI
+44.03%
$1.57
ACHR
+2.46%
$13.08
GPUS
-6.62%
$0.40
AMD
+3.30%
$223.58
TSLA
-0.54%
$433.54
WULF
+12.21%
$15.71
ETHD
+5.41%
$3.51
TLRY
-2.96%
$1.63
MARA
+11.24%
$22.51
MP
+21.34%
$95.06
ERIC
+19.76%
$9.78
QBTS
+7.17%
$43.53
SOUN
+9.19%
$20.90
NUAI
+28.95%
$3.03
UUUU
+11.50%
$26.50
BTBT
+7.50%
$4.30
RR
+0.79%
$6.50
UAMY
+36.85%
$16.71
AAL
+3.79%
$12.18
KDLY
-1.56%
$0.85
RIG
-2.34%
$3.12
BBD
+2.34%
$3.16
CLF
+2.20%
$14.13
SOFI
+3.38%
$28.05
NOK
-1.31%
$5.25
JDZG
+44.14%
$2.71
CIFR
+3.93%
$21.14
AREC
+30.92%
$6.51
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AMZN
+1.71%
$220.07
ADAP
-10.05%
$0.16
CLSK
+11.02%
$22.25
IREN
+9.35%
$70.14
APLD
+4.26%
$35.70
USAR
+2.43%
$39.62
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
BTG
+1.22%
$5.37
NIO
-3.06%
$6.95
WWR
+21.67%
$3.11
ABAT
+18.65%
$10.94
QUBT
+3.86%
$22.29
QS
-1.38%
$16.75
ASST
-5.09%
$1.02
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RF
+2.42%
$25.15
BMNR
-4.52%
$54.28
ONDS
-3.93%
$10.38
WLGS
-5.57%
$0.04
SNAP
-0.64%
$7.99
ETWO
0.00%
$3.30
JBLU
+9.45%
$4.98
GWH
-19.99%
$7.24
AMC
-2.71%
$2.87
RGTZ
-3.00%
$9.02
EOSE
+2.55%
$17.48
PFE
-0.14%
$24.69
WFC
+8.33%
$85.49
NB
+6.80%
$12.09
BCRX
-11.29%
$6.24
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
HPE
+1.73%
$25.23
BAC
+3.18%
$50.41
ABEV
+1.40%
$2.17
AQMS
+140.56%
$23.84
GWAV
+88.96%
$16.08
GDXD
+0.44%
$0.73
GRAB
+0.59%
$5.96

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.